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Pat1The translational regulation of maternal mRNAs is one of the most important steps in the control of
temporal–spatial gene expression during oocyte maturation and early embryogenesis in various species.
Recently, it has become clear that protein components of mRNPs play essential roles in the translational
regulation of maternal mRNAs. In the present study, we investigated the function of P100 in Xenopus oocytes.
P100 exhibits sequence conservation with budding yeast Pat1 and is likely the orthologue of human Pat1a
(also called PatL2). P100 is maternally expressed in immature oocytes, but disappears during oocyte
maturation. In oocytes, P100 is an RNA binding component of ribosome-free mRNPs, associating with other
mRNP components such as Xp54, xRAP55 and CPEB. Translational repression by overexpression of P100
occurred when reporter mRNAs were injected into oocytes. Intriguingly, we found that when P100 was
overexpressed in the oocytes, the kinetics of oocyte maturation was considerably retarded. In addition,
overexpression of P100 in oocytes signiﬁcantly affected the accumulation of c-Mos and cyclin B1 during
oocyte maturation. These results suggest that P100 plays a role in regulating the translation of speciﬁc
maternal mRNAs required for the progression of Xenopus oocyte maturation.emistry, RIKEN, 2-1 Hirosawa,
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Translational control ofmRNAs is a primary regulatory step of gene
expression during animal early development (Davidson, 1986).
Protein synthesis depends on maternally inherited and stored
mRNAs, mainly because transcription is highly restricted due to
chromatin condensation in two consecutive M-phases during oocyte
maturation and the necessity for rapid cell cycle progression during
early embryogenesis. Xenopus laevis has long served as a good model
to study the translational repression (masking) and subsequent
activation (unmasking) of maternal mRNAs. A large pool of mRNAs is
sequestered in the oocyte cytoplasm as stored mRNPs that are
biochemically fractionated as ribosome-free mRNPs (Darnbrough and
Ford, 1981; Tafuri and Wolffe, 1993).
The precise timing of the translational activation of eachmRNA stored
in oocytes is mainly mediated by speciﬁc cis-elements, most of which
reside in the 3′ untranslated regions (UTRs) of mRNAs, and their cognate
binding proteins (and possibly microRNAs) (Mowry and Cote, 1999;
Colegrove-Otero et al., 2005). When Xenopus oocytes are induced tomature by progesterone, translational activation of c-mos mRNA, which
encodes a MAP kinase kinase kinase, and subsequent MAP kinase
signaling are prerequisites for the cytoplasmic polyadenylation and
translational activation of cyclin B1 mRNA (Ballantyne et al., 1997; de
Moor and Richter, 1997; Radford et al., 2008). Both c-mos and cyclin B1
mRNAs contain cis-elements called cytoplasmic polyadenylation ele-
ments (CPEs) (Fox et al., 1989;McGrew et al., 1989;McGrew and Richter,
1990; Sheets et al., 1994; Richter, 2007). Their cognate binding protein
CPEB has been well-characterized to be required both for translational
repression in immature oocytes and for cytoplasmic polyadenylation-
dependent translational activation inmaturingoocytes (HakeandRichter,
1994; Stebbins-Boaz et al., 1996; de Moor and Richter, 1999; Richter,
2007).More recently, the early translational activationof c-mosmRNAhas
been shown to be dependent on Musashi, which binds to a polyadenyla-
tion response element (PRE) in the c-mos 3′UTR (Charlesworth et al.,
2002, 2006),whereas Pumilio is involved in the timing of the translational
activation of cyclin B1mRNA (Nakahata et al., 2001, 2003).
The translational efﬁciency of an mRNA is also regulated by a set of
proteins associatingwith it. Protein components of cytoplasmicmRNPs in
Xenopus oocytes have been biochemically identiﬁed by sucrose gradient
centrifugation and oligo(dT) cellulose chromatography. In previtellogenic
oocytes, four abundant (50, 52, 56 and 59 kDa, named mRNP1–4,
respectively) and less abundant (75, ∼100, 16 and 22 kDa, named
mRNP5–8, respectively)proteinsare co-fractionatedwithpolyA+RNAsas
free mRNPs (Darnbrough and Ford, 1981). Subsequently, ﬁve proteins
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mRNA (Murray et al., 1991). mRNP3 and mRNP4, which are identical to
p54 and p56, respectively, aremembers of the Y-box protein family, with
mRNP4 being identical to the Y-box protein FRGY2 (Tafuri and Wolffe,
1990;Deschampset al., 1992;Murray et al., 1992). Y-boxproteins are core
components ofmRNPs in higher eukaryotes, and likely responsible for the
packaging of mRNAs into mRNPs (Matsumoto and Wolffe, 1998;
Matsumoto et al., 2003; Skabkin et al., 2004). The addition of a sufﬁciently
excess of Y-box proteins into in vitro translation systems or over-
expression in cultured cells leads to the translational repression of
reporter mRNAs (Matsumoto et al., 1996; Davydova et al., 1997; Tanaka
et al., 2004). Later studies identiﬁed other components of mRNPs
including the DEAD-box ATPase Xp54, the embryonic poly(A) binding
proteins ePAB and ePABP2, xRAP55, 4E-T and the oocyte-speciﬁc eIF4E1b
that binds to the cap weakly (Ladomery et al., 1997; Voeltz et al., 2001;
Good et al., 2004; Cosson et al., 2004; Tanaka et al., 2006; Minshall et al.,
2007). Importantly, Xp54, RAP55 and 4E-T were shown to repress
translation in vitro and/or in oocytes,whereas ePAB stimulates translation
(Minshall et al., 2001; Tanaka et al., 2006; Wilkie et al., 2005; Minshall et
al., 2007). TheY-boxprotein, thehomologuesofXp54, andRAP55possibly
constitute the abundant and conserved components of maternal mRNPs
of different organisms (Audhya et al., 2005; Boag et al., 2005; Wilhelm et
al., 2005; Tanaka et al., 2006). Their involvement in translational
repression in a wide range of organisms is further supported by the fact
that they are found in processing bodies (P-bodies) and stress granules,
discrete cytoplasmic foci where non-translating mRNAs accumulate
(Cougot et al., 2004; Tanaka et al., 2006; Yang et al., 2006; Suzuki et al.,
2009).
We previously isolated FRGY2-containing complexes from Xenopus
oocytes and identiﬁed xRAP55 in these complexes (Tanaka et al., 2006).
Wehereafter refer to thisproteinasxRAP55A, since recentlyxRAP55Bwas
identiﬁed in small oocytes (Minshall et al., 2007; Marnef et al., 2009). In
the same complexes, we identiﬁed P100, which was originally puriﬁed
fromXenopus oocytes as a protein recognized by scleroderma patient sera
(Tanaka et al., 2006; Rother et al., 1992). Although P100 was shown to
bind to single-stranded DNA, it has not been characterized in detail. P100
exhibits sequence conservation with budding yeast Pat1p. Pat1p is
involved in mRNA degradation by activating mRNA decapping, function-
ing together with the Lsm1p-7p heptameric complex (Bonnerot et al.,
2000; Bouveret et al., 2000; Tharun et al., 2000). Pat1p also acts as a
general translational repressor in yeast (Coller and Parker, 2005),
although an earlier report has shown that Pat1 is involved in translation
initiation (Wyers et al., 2000). In yeast, Dhh1p, the orthologue of Xp54, is
also required for global translational repression of mRNAs, targeting
mRNAs fordecapping, andpromoting their assembly intoP-bodies (Coller
and Parker, 2005). It has been shown that yeast Lsm1p-7p, Pat1p and
Dhh1p form a complex to enhance the decapping (Coller and Parker,
2004).
In this study, we examined the function of P100 in Xenopus oocytes.
We found that P100 was already present in the smallest oocytes and
disappeared during oocyte maturation. In oocytes, P100 is an RNA
binding component of ribosome-freemRNPs. Furthermore, overexpres-
sion of P100 repressed the translation of reportermRNAs.Wealso found
that when P100 was overexpressed by microinjecting P100mRNA, the
kinetics of oocyte maturation was considerably retarded. Overexpres-
sion of P100 signiﬁcantly affected the accumulation of c-Mos and cyclin
B1 both of which are normally synthesized during oocyte maturation.
Our data suggest that P100 is involved in the translation of maternal
mRNAs required for the progression of oocyte maturation.
Materials and methods
Oocyte preparation and microinjection
X. laevis oocytes were obtained by surgical removal of ovaries from
mature female frogs and treatment with collagenase. Stage VI oocytesweremicroinjectedwith30–45 ngof in vitro transcribedmRNAor 20 ng
of morpholino antisense oligonucleotides (MO, Gene Tools) and
maintained at 18 °C for 12–15 h (Matsumoto et al., 1998). MO used
were: P100, 5′-GTTCGGAGCCGAGATTCATGTTTGC-3′ and control, 5′-
CCTCTTACCTCAGTTACAATTTATA-3′. Maturation was induced by incu-
bating the oocytes in modiﬁed Barth's solution (MBSH) containing
progesterone (5 µM). The oocytes were collected at appropriate
intervals and scored for GVBD to examine the effects of mRNAs on
oocyte maturation. Oocyte lysates were prepared as described previ-
ously (Matsumoto et al., 1999). Lysates from stage VI and matured
oocytes were treated at 30 °C for 30 min with lambda protein
phosphatase (New England Biolabs) in a buffer supplied by the
manufacturer in the presence of Complete EDTA-free protease inhibitor
cocktail (Roche) (Suzuki et al., 2009).Antibodies and immunoblotting
Immunoblotting was performed as described previously (Matsumoto
et al., 1999). Rabbit polyclonal antibodies against P100 and xPat1b were
raised against synthetic peptides, EDKMECPVIPPYTAVPS, corresponding
to the C-terminal region of P100, and CQFRPDTTHLHPQHRRM,
corresponding to an internal region of xPat1b, respectively (see Fig. S1).
Antibodies against FRGY2 (Tafuri and Wolffe, 1992), xRAP55A (Tanaka
et al., 2006), TAF-I (a gift fromDr. K. Nagata), cyclin B1 (a gift fromDr. J. L.
Maller), Lsm1 (Abcam), c-Mos andErk1 (SantaCruz),β-actin (Sigma) and
CPEB (IMGENEX) were used as primary antibodies.Immunocytochemistry of Xenopus oocytes
Polyclonal antibodies against P100 were afﬁnity-puriﬁed with an
antigen peptide column. For immunocytological staining, oocytes were
ﬁxed with 100% methanol and embedded in Polyester Wax (BDH
Chem., UK). Sectioned specimens were stained with primary and
secondary antibodies as described previously (Tanaka et al., 2004). The
primary antibodies were used at a ﬁnal concentration of 2 µg/ml. The
secondary antibodies were Alexa Fluor 488-conjugated goat anti-rabbit
IgG antibodies (2 µg/ml, Molecular Probes). The specimens were
observed under a ﬂuorescence microscope (Olympus, AX70).Immunoprecipitation
Stage I–III oocytes (200 µl) were homogenized in 500 µl of buffer C
(20 mM HEPES [pH 7.5], 2 mM MgCl2, 1 mM dithiothreitol [DTT] and
0.5 mM phenylmethylsulfonyl ﬂuoride) containing 100 mM KCl, as
described previously (Aoki et al., 2003). The lysates were cleared by
centrifugation at 18,000×g at 4 °C for 10 min. The lysates were treated
with 50 µg/ml RNase A at 37 °C for 10 min,where indicated. The oocyte
lysates were incubated with afﬁnity-puriﬁed anti-P100 antibodies
bound to protein A-agarose or protein G-Sepharose in buffer C
containing 100 mM KCl at 4 °C for 2–3 h. After extensive washing
with buffer C containing 175 mM KCl, complexes containing P100
proteins were eluted with 700 µg/ml of the P100 antigen peptide in
20 mMHEPES [pH7.5]–150 mMKCl at room temperature for 5 min. The
eluates were analyzed in a SDS-polyacrylamide gel. Tandem mass
spectrometric analyses of the tryptic peptides were carried out at the
Research Resources Center at our institute. RNA was prepared from
oocyte lysates and immunoprecipitates and used as templates for
reverse transcriptase-mediated PCR (RT-PCR). Primers used were: c-
mos, 5′-AGTGTCATTCTCTGATCGG-3′ and 5′-CATCCTATCAAAGGAA-
GAC-3′; cyclin B1, 5′-AGGAGACAATGTTCATGAC-3′ and 5′-ACG-
TAGTCCTTCACATGAG-3′; RINGO, 5′-GATGAGGTAATGGCGAAAG-3′
and 5′-GGCAAGTATTATTCTCCAC-3′;β-globin, 5′-AAGACTATTGGACAA-
GAGG-3′ and 5′-TATGTAGCTTAGAGACTCC-3′.
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Sucrose gradient fractionation of oocyte lysates was performed
essentially as described previously (Matsumoto et al., 2000; Tanaka
et al., 2006). Twenty stage VI oocytes were homogenized in 200 µl of
buffer A (20 mM Tris–HCl [pH 7.5], 50 mM NaCl, 2 mM MgCl2, 1 mM
DTT, 10 µg/ml cycloheximide and 25 U/ml RNase inhibitor). The
homogenate was centrifuged in a microtube at 18,000×g at 4 °C for
10 min. The supernatant was loaded on a 15–40% sucrose density
gradient prepared in buffer A and centrifuged at 280,000×g in a
Hitachi P50S2 rotor at 4 °C for 2 h. For the EDTA treatment, all the
buffers contained 20 mM EDTA instead of MgCl2 and cycloheximide.
Oligo(dT)-cellulose chromatography and UV-crosslinking assay
Oligo(dT)-cellulose chromatography following UV-crosslinking was
performed as described previously (Tanaka et al., 2006) using 200 µl of
stage I–III oocytes.
Constructs
cDNAs for P100 (EXL1051-4011859, accession number BI449406)
and xPat1b (EXL1051-97080295, accession number BC108769) were
obtained from Open Biosystems. To generate a construct for the N-
terminal MS2-tagged P100 mRNA (pMS2-P100), the P100 coding
sequencewas ampliﬁed by PCR from the P100 cDNAwith a primer set,
5′-CTAGCTAGCATGAATCTCGGCTCCGAAC-3′ and 5′-CTAGCTAGCT-
GAAGGTACAGCTGTGTAC-3′. The PCR fragment was digested with
NheI and cloned into pMSP-poly(A)60 (Tanaka et al., 2006).
A construct for the C-terminal FLAG-tagged P100 mRNA (pP100-
FLAG-C) was generated as follows. Two oligonucleotides, 5′-AGCTTG-
GAAGATCTTCCCCCGGGGGTTACCGACTAGTGATTATAAAGATCATGA
CATCGACTACAAGGATGACGATGACAAGTGAC-3′ and 5′-AGCTGT-
CACTTGTCATCGTCATCCTTGTAGTCGATGTCATGATCTTTATAATCAC-
TAGTCGGTAACCCCCGGGGGAAGATCTTCCA-3′, were annealed and
cloned into the HindIII site of pGEM-pA+ (Aoki et al., 2003) to generate
pGEM-FLAG encoding the 2xFLAG sequence. The P100 coding sequence
was ampliﬁed by PCR from the P100 cDNA with a primer set, 5′-
GAAGATCTCGCAAACATGGATCTCGG-3′ and 5′-GACTAGTTGAAGGTA-
CAGCTGTGTAC-3′. The PCR fragment was then digested with BglII and
SpeI and the resulting fragment was cloned into pGEM-FLAG to obtain
pP100-FLAG-C.
To generate a construct for the N-terminal FLAG-tagged P100 mRNA
(pN-FLAG-P100), the P100 coding sequence was ampliﬁed by PCR from
P100 cDNA with a primer set, 5′-GAAGATCTCGCAAACATGGATCTCGG-3′
and 5′-TCTAGAGGATCCTCATGAAGGTACAGCTGTG-3′ containing a termi-
nation codon. The PCR fragment was digested with BglII and BamHI and
cloned into the p3xFLAG-CMV10 expression vector (Sigma) to obtain
pCMV10-P100. The 3xFLAG-P100 coding sequence was ampliﬁed by PCR
from pCMV10-P100 with a primer set, 5′-CTCTAGACTAGTATGGACTA-
CAAAGACCATG-3′ and 5′-CTCTAGACTAGTTCATGAAGGTACAGCTGTG-3′.
The PCR fragment was digested with SpeI and cloned into pGEM-FLAG to
obtain pN-FLAG-P100. pMS2-P100, pP100-FLAG-C and pN-FLAG-P100
were linearized with NsiI and used for in vitro transcription with a
mMESSAGE mMACHINE SP6 kit (Ambion).
To generate a construct for the xPat1b mRNA, the xPat1b coding
sequence was ampliﬁed by PCR from xPat1b cDNA with a primer set,
5′-GGGAATTCCATATGGAGTCTCTAGTTGATGGTG-3 ′ and 5′-
CCGCCGCTCGAGTAGTGTGCCGTTAGTTGATCCAAGC-3′. The PCR frag-
ment was digested with NdeI and XhoI and cloned into pET24b vector
(Novagen) to obtain pET-xPat1b. This plasmid was linearized with
Bpu1102I and used for in vitro transcription with T7 RNA polymerase.
To generate a construct for the Rluc-β-globin reporter mRNA, a
cDNA of Renilla luciferase was inserted into EcoRI–BamHI sites of
pGEM11Zf(+) (Promega) to obtain pGEM-Rluc. The 3′UTR of Xenopus
β-globin mRNA was obtained by RT-PCR from Xenopus oocyte RNAwith a primer set, 5′-GAGCGCGGATCCACCAGCCTCAAGAACACC-3′
and 5′-ATGCATCAAGCTTAGAATGTGAAGAAACTTTC-3′. The PCR frag-
ment was digested with BamHI and HindIII and cloned into pGEM-
Rluc to obtain pGEM-Rluc-β-globin. Other constructs were described
in Tanaka et al. (2006) (Tanaka et al., 2006).
Tethering assay
The mRNAs (30–40 ng) encoding MS2 and MS2-P100 were injected
into stage VI oocytes. After 6 h, the oocyteswere injectedwith 1.5–2 ng of
luciferase reporter mRNA. Oocytes were then homogenized in 20 µl per
oocyte of protein homogenization buffer (90 mM Hepes pH7.5, 70 mM
KCl, 5% sucrose and 1 mMDTT) and 5-µl and 15-µl samples were assayed
for ﬁreﬂy luciferase activity. To analyze mRNA stability, [32P]-labeled
mRNAs were injected as above and RNA was recovered with TRI reagent
(Sigma) and analyzed by electrophoresis in an agarose gel containing
formaldehyde. The gels were dried and exposed to an imaging plate. The
radioactivity was quantiﬁed using a BAS2500 Image Analyzer (Fuji Film).
Analysis of protein synthesis activity
To analyze the protein synthesis in oocytes injected with P100-
FLAG-C, MS2 or MS2-P100 mRNA, oocytes were incubated with [35S]
methionine and cysteine (100 µCi/ml, GE Healthcare) for 16–19 h.
Oocytes were then homogenized in the protein homogenization
buffer and analyzed by SDS-PAGE. The gels were dried and exposed to
an imaging plate. The radioactivity of the translational products was
quantiﬁed using a BAS2500 Image Analyzer.
Real time PCR
RNA was isolated from stage VI oocytes and matured oocytes with
TRI reagent and cDNA was obtained using SuperScript III ﬁrst strand
synthesis system (Invitrogen). The amount of individual mRNA was
determined by quantitative PCR using SYBR Premix EX Taq II and
Thermal Cycler Dice real time system (Takara). The primers used
were: ornithine decarboxylase (ODC), 5′-GCCATTGTGAAGACTCTCTC-
CATTC-3′ and 5′-TTCGGGTGATTCCTTGCCAC-3′ (Arthur et al., 2009);
cyclin B1, 5′-GGATGCACAAGCAGTCAGACAAA-3′ and 5′-ACCTGGAC-
CAGCCAGTCAATCA-3′; c-mos, 5′-TGGCGCTGAAGAAGGTAAAACG-3′
and 5′-GTTCAGTTCGGCCCAGAAGCT-3′.
Histone H1 kinase assay
H1 kinase assays were performed essentially as described (Walter
et al., 1997; Iwabuchi et al., 2000). Oocytes were homogenized in 20 µl/
oocyte of kinase buffer (80 mMβ-glycerophosphate, 20 mMEGTA, 5 mM
MgCl2, 20 mM Hepes pH7.5, 1 mM DTT, 0.1% NP-40 and 1 × Complete
EDTA-free protease inhibitor cocktail (Roche)) and cleared by centrifu-
gation at 18,000×g at 4 °C for 10 min. Oocyte lysates equivalent to half an
oocyteweremixedwith10 µl of amixture containing2.5 µgof histoneH1
(Roche), 0.4 mM ATP, 1 µCi [γ-32P]ATP, 20 µM cAMP-dependent kinase
inhibitor (Promega) and200 µg/mlbovine serumalbumin, and incubated
at 30 °C for 10 min. The reactions were stopped by adding SDS-PAGE
sample buffer. Proteins were analyzed by SDS-PAGE.
Results
Temporal and spatial expression of P100
Wepreviously identiﬁedP100asacommoncomponentof FRGY2-and
xRAP55A-containing RNPs isolated from Xenopus oocytes (Tanaka et al.,
2006). P100 has sequence conservation with budding yeast Pat1p.
Recently, two Pat1p homologues in mammals, Pat1b/PatL1 and Pat1a/
PatL2, were identiﬁed (Scheller et al., 2007). Pat1b/PatL1 mRNA is
expressed ubiquitously in humans and mice, while Pat1a/PatL2
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mice ((Scheller et al., 2007); NCBI UniGene's EST ProﬁleViewer at http://
www.ncbi.nim.nih.gov/UniGene). Xenopus P100 is expressed only in the
ovary (Rother et al., 1992) and has a higher degree of sequence
conservation with Pat1a/PatL2 than with Pat1b/PatL1 (Fig. 1A). A
database search led to the identiﬁcation of Xenopus Pat1b (xPat1b)
(Figs. 1A and S1). Thus, there seems to be two Pat1 homologues in
metazoans, one expressed ubiquitously and the other expressed in
reproductive tissues.
To facilitate characterization of xPat1a/P100, we have raised a
polyclonal antibody against a synthetic peptide corresponding to the
P100C-terminus. This antibodyreactedwitha∼100 kDaprotein inoocyte
lysates (Fig. 1B), as well aswith a recombinant P100 expressed in oocytes
(see Fig. 5B). Using this antibody, we examined the expression of P100 in
oocytes, eggs and early embryos (Fig. 1C). P100 was already expressed in
the smallest stage I oocytes and the amount of P100 decreased during
oocyte growth until stage VI, essentially as reported (Rother et al., 1992;
Minshall et al., 2007). These expression patterns are in contrast to those of
xRAP55A (Fig. 1C, Tanaka et al., 2006) and FRGY2 (data not shown), both
ofwhich increase during oogenesis. Strikingly, P100 becameundetectable
in unfertilized and fertilized eggs and remained absent in early embryos
until the tailbudstage(Fig. 1C). These results raise thepossibility thatP100
disappears during oocytematuration. To examine this,we treated stageVI
oocytes with progesterone to induce maturation. The immature oocytes
that havebeenarrested at prophase ofmeiosis I resumemeiosis under theFig. 1. Temporal expression of P100 protein. (A) Phylogenetic tree of Pat1 family members. Xen
Pat1a (AAI45647, ClustalWscore36.2) than toXenopusPat1b (AAI08770, score 23.0),mouse Pat
lysates from stage VI oocyteswith anti-P100 antibody or preimmune serum. (C) Temporal expr
Lysates equivalent to 0.5 oocytes (stages I through VI), unfertilized egg (UF), fertilized egg (F),
neurula (N) and tailbud (TB) were analyzed by immunoblotting. (D) Disappearance of P100 in
Individual oocytes without (−) or with (+) a white spot, indicative of GVBD, were lysed and a
disappearance of P100 inmatured oocytes. The stage VI oocytes were incubated in the absence
white spots (0 h), or at the indicated time points after the appearance of white spots. Proteinscontrol of progesterone and become arrested atmetaphase ofmeiosis II at
the end of oocyte maturation. The resumption of meiosis is characterized
visuallyby theappearanceof awhite spoton theanimalpoleof theoocyte,
which is the consequence of germinal vesicle breakdown (GVBD). When
GVBD occurred in 50% of the progesterone-treated oocytes, each oocyte
without or with awhite spot was individually lysed and assayed for P100
by immunoblotting. We found that the amount of P100 was signiﬁcantly
smaller in the oocytes with white spots than those without white spots,
while the amount of xRAP55Adid not change appreciably (Fig. 1D). These
results imply that P100 decreases depending on the progression of oocyte
maturation. This notion was further supported by a time-course expe-
riment showing that the amount of P100 rapidly decreased in pools of
oocytes collected immediately after GVBD and thereafter at 1-h intervals
(Fig. 1E).
We also raised a polyclonal antibody against a synthetic peptide
corresponding to an internal region of xPat1b. This antibody detected
putative endogenous xPat1b, which co-migrated with overexpressed
recombinant xPat1b in stage VI oocytes (Fig. S2A). This antibody also
reacted with P100, probably because the similarity between amino
acid sequences of the antigen peptide and of the corresponding region
in P100 (Fig. S1). xPat1b started to accumulate from stage IV oocytes
and was expressed throughout early embryogenesis (Figs. S2B–D).
This expression pattern of xPat1b is in sharp contrast to P100, which
disappeared during oocyte maturation, suggesting a switchover from
P100 to xPat1b. xPat1b was detected as a doublet in oocytes and onlyopus P100 (Genbank accession number NP_001085311) is more closely related to mouse
1b (AAH58941, score 25.0) and yeast Pat1p (CAC42990, score 11.9). (B) Immunoblotting of
ession of P100 during oogenesis (upper panels) and early embryogenesis (bottom panels).
or embryos at the 2-cell, 4-cell, 8-cell, 16-cell and 32-cell stages, blastula (B), gastrula (G),
matured oocytes. Stage VI oocytes were stimulated with progesterone to mature for 8 h.
nalyzed by immunoblotting with anti-P100 and anti-xRAP55A antibodies. (E) The gradual
(−) or presence (+) of progesterone. Oocytes were collected just after the appearance of
were analyzed by immunoblotting with anti-P100 and anti-xRAP55A antibodies.
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(Figs. S2C and D). This represents phosphorylation, because the slow
migrating formwas disappeared by phosphatase treatment (Fig. S2E).
P100 was predominantly located in the oocyte cytoplasm, as judged
by immunoblotting of the nuclear and cytoplasmic fractions of stage VI
oocytes (Fig. 2A). As a control, template activating factor I (TAF-I),which
is involved in chromatin remodeling, was exclusively detected in the
nuclear fractions (Matsumoto et al., 1999). The cytoplasmic localization
of P100was conﬁrmedby the immunostainingof oocytes (Fig. 2B). P100
was distributed evenly in the oocyte cytoplasm throughout oogenesis.
Although the mRNP component xRAP55A was localized to cytoplasmic
foci in stage VI oocytes (Tanaka et al., 2006), localized signals for P100
were not obvious.P100 is an RNA binding component of stored mRNPs in oocytes
Given that P100 was coimmunoprecipitated with FRGY2 and
xRAP55A (Tanaka et al., 2006), we examined whether P100 is a
component of cytoplasmicmRNPs. Lysates from stage VI oocytes were
fractionated on a sucrose gradient in the presence of cycloheximide
and the distribution of P100 was examined. P100 was distributed
predominantly in fractions lighter than ribosomes, corresponding to
fractions containing non-translating (storage) mRNPs (Fig. 3A).
FRGY2 was mainly detected in non-translating mRNP fractions with
minor portions in mRNA-free fractions and ribosomal fractions, as
reported previously (Tanaka et al., 2006). To verify our observation,
oocyte lysates were treated with EDTA and fractionated on a sucrose
gradient containing EDTA, under which conditions ribosomes and
their subunits are released from mRNAs. The EDTA treatment did notFig. 2. Spatial expression of P100 protein. (A) Total lysate (T) and nuclear (N) and cytoplasmi
anti-TAF-I antibodies. (B) Sections of stage I–II, III, and VI oocytes were stained with anti-P10
Scale bar, 100 µm.change the distribution of P100 signiﬁcantly, indicating that P100
predominantly exists in the ribosome-free mRNP fractions (Fig. 3B).
Because P100 was reported to bind to single-stranded DNA
cellulose, it may bind to mRNA directly, as is also the case for most
of the protein components of mRNPs identiﬁed to date (Colegrove-
Otero et al., 2005; Matsumoto, 2006). Yeast Pat1p has been shown to
bind to RNA (Pilkington and Parker, 2008). Alternatively, it is possible
that P100 associates with mRNA indirectly through protein–protein
interaction. To distinguish between these possibilities, we examined
whether P100 is directly associated with adenylated RNAs in oocytes.
To do this, oocyte lysates were irradiated to UV and subjected to oligo
(dT)-cellulose chromatography. The oligo(dT)-cellulose was then
washed with a buffer containing SDS, with which proteins not
crosslinked to adenylated RNAs would have been washed away, and
the bound fractions were analyzed after digestion with an RNase for
the presence of P100. The immunoblotting revealed that P100 was
retained on the oligo(dT)-cellulose depending on the UV-crosslinking
as was FRGY2. In contrast, β-actin was not retained on the oligo(dT)-
cellulose. These results demonstrate that P100 directly associate with
adenylated RNA (Fig. 3C).
To identify which set of proteins are associated with P100 in
oocytes, lysates from early stage oocytes (stages I–III), in which P100
is abundant (Fig. 1C), were used for immunoprecipitation with the
anti-P100 antibody. When eluted by incubation with the antigen
peptide, a number of proteins were speciﬁcally coimmunoprecipi-
tated with P100 (Fig. 3D). The various bands were excised from the
gel and proteins were identiﬁed by mass spectrometry. The identiﬁed
proteins included 4E-T, ePAB, FRGY2, CPEB, xRAP55B and Xp54, all of
which were known to be mRNP constituents in oocytes (Tanaka et al.,
2006; Minshall et al., 2007). Among them, 4E-T, FRGY2, CPEB andc (C) fractions of stage VI oocytes were analyzed by immunoblotting with anti-P100 and
0 antibody or rabbit IgG. The germinal vesicle (GV) and vegetal region (V) are indicated.
Fig. 3. P100 is an RNA binding component of cytoplasmic mRNPs. (A, B) Stage VI oocyte lysates were fractionated on a sucrose gradient in the presence of cycloheximide (A) or EDTA
(B). Proteins from each fraction were analyzed by immunoblotting with anti-P100 and anti-FRGY2 antibodies. Absorbance proﬁles at 254 nm are shown. (C) Oocyte lysates were
irradiated with UV light (lane 3) or not irradiated (lane 2) and subjected to oligo(dT) cellulose chromatography. After extensive washes with a buffer containing SDS, bound proteins
were eluted and digested with RNase. Lysate (lane 1) and eluates (lanes 2 and 3) were analyzed by immunoblotting. (D) Isolation of a P100-associated complex by
immunoprecipitation. Lysates were prepared from small oocytes (stages I–III). In lane 2, the lysates were treated with RNase. The lysates were incubated with anti-P100 antibody
beads (lanes 1 and 2) or with rabbit IgG beads (lane 4). Anti-P100 antibody beads were incubated without lysate (lane 3). Bound proteins were resolved by SDS-PAGE and detected
by silver staining (left). Relevant bands in lane 1 were analyzed by mass spectrometry, and proteins identiﬁed are listed on the right. A band corresponding to 48 kDa in lane 2
(indicated by an asterisk) was also analyzed and EF-1αwas identiﬁed. P100, xRAP55A, Xp54, FRGY2 and Lsm1 in the immunoprecipitates were detected by immunoblotting (right).
(E) Identiﬁcation of P100-associating mRNAs. RNA was recovered from oocyte lysates and the immunoprecipitates either with anti-p100 antibody or rabbit IgG, and used as
templates for RT-PCR.
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we identiﬁed the mRNA binding proteins Vera and ElrB, and zygote
arrest 1 whose mouse homologue was shown to be a maternal effect
gene (Wu et al., 2003). Elongation factor-1α (EF-1α), the mostabundant protein in previtellogenic oocytes (Mattaj et al., 1987), was
found as a major protein in the RNase-treated samples. We tried to
conﬁrm these results by immunoblotting of the immunoprecipitates
with antibodies against mRNP components, and found that xRAP55A
278 Y. Nakamura et al. / Developmental Biology 344 (2010) 272–283in addition to FRGY2 and Xp54was coimmunoprecipitated with P100.
Moreover, we found that P100was coimmunoprecipitatedwith Lsm1,
as is the case for Pat1p in yeast (Bonnerot et al., 2000; Bouveret et al.,
2000; Tharun et al., 2000). RNase-treatment prior to immunoprecip-
itation revealed that Lsm1, Xp54 and xRAP55A are associated with
P100 in an at least partially RNA-independent manner. In contrast,
FRGY2 was not coimmunoprecipitated with P100 from RNase-treated
lysates. To examinewhethermRNAs are associatedwith P100, RT-PCR
was performed using RNA recovered from immunoprecipitates with
anti-p100 antibody or with rabbit IgG (Fig. 3E). P100-interacting
mRNAs included cyclin B1, c-mos and RINGO mRNAs. Taken together,
these data further support the idea that P100 together with its
associating proteins constitutes cytoplasmic mRNPs with maternal
mRNAs in Xenopus oocytes.
P100 represses translation in oocytes
The above data revealed that P100 is an RNA binding component of
mRNPs. Yeast Pat1p has been shown to be a general repressor of
translation (Coller and Parker, 2005). We therefore investigated
whether P100 plays a role in translational regulation. We ﬁrst tested
the effect of overexpression of P100 on global protein synthesis in stage
VI oocytes. Oocytes were microinjected with an in vitro synthesized
mRNA encoding C-terminally FLAG-tagged P100 (P100-FLAG-C) and
incubated for 16–18 h to allow protein production. By incubating the
oocytes with [35S] methionine and cysteine and analyzing the newly
synthesized proteins by SDS-PAGE, we found that overexpression of
P100 did not have an apparent effect on global protein synthesis
(Fig. 4A).
We then hypothesized that P100 would affect the translation of
mRNAs when forced to bind to them. To test this, we tethered P100 to
the 3′UTR of ﬁreﬂy luciferase (Luc)mRNA. mRNAs encoding eitherMS2
coat protein or MS2 fused to P100 were microinjected into oocytes
(Fig. 4B). After incubation of the oocytes for 6 h to allow protein
synthesis, capped luciferasemRNAs either containingMS2-binding sites
(Luc-MS2) or not containing them (Luc-ΔMS2) were then injected. In
contrast to no detectable effect on global translation, the expression of
MS2-P100 repressed luciferase activity from Luc-ΔMS2mRNA to ∼35%
compared with that of MS2 protein alone (Fig. 4C). The luciferase
activity from Luc-MS2mRNA was further repressed by MS2-P100 (20%
of control). 32P-labeled reporter mRNAs were equally stable in oocytes
expressingMS2 orMS2-P100, suggesting the reduced luciferase activity
tobedue todifferences in translation not in reportermRNAstability.We
conclude that P100 mediates the translational repression of the Luc
reporter mRNA and this effect is augmented by tethering through MS2
and its binding sites. To examine whether the observed translational
repression by P100 is speciﬁc for Luc mRNA, we used two additional
reporter mRNAs that do not contain MS2-binding sites. Interestingly,
when chloramphenicol acetyltransferase (CAT) mRNA was injected into
MS2- or MS2-P100-expressing oocytes, virtually no translational
repression was observed (Fig. 4D). In contrast, P100-FLAG-C repressed
translation of Renilla luciferasemRNA connected to Xenopus β-globin 3′
UTR (Fig. 4E). These results suggest that P100 represses translation of a
subset of mRNA.
Effect of P100 on the kinetics of meiotic maturation
After the triggering of meiotic maturation by progesterone, oocytes
activate the translation of speciﬁcmRNAs by recruiting themRNAs from
storagemRNPs to ribosomes in anmRNA-speciﬁcmanner dependingon
the progression of maturation. As P100 disappears during oocyte
maturation,we investigatedwhether P100has a role in the regulation of
oocyte maturation by overexpressing P100mRNA. P100-FLAG-CmRNA
was injected into stage VI oocytes and the oocyteswere stimulatedwith
progesterone to undergo meiotic maturation. The protein level of the
exogenously expressed P100-FLAG-C was about the same as that of theendogenous P100 in immature oocytes. Oocytes overexpressing P100-
FLAG-C underwentmaturation very poorly, only∼40% of them showing
GVBD 10 h after the progesterone treatment, at which time oocytes
uninjected or injectedwith the xRAP55AmRNAunderwent almost 100%
maturation (Fig. 5A). When oocytes were injected with one-tenth the
amount of P100-FLAG-C mRNA, only a slight retardation of oocyte
maturation kinetics was observed, suggesting that the effect of P100
overexpression was dose-dependent. We noticed that, whereas the
endogenous P100 in oocytes both uninjected and injected with P100-
FLAG-CmRNA almost disappeared uponmaturation, the protein level of
the expressed P100-FLAG-C was not discernibly changed in matured
oocytes compared to that in oocytes untreated with progesterone
(Fig. 5B). To exclude the possibility that this behavior of P100-FLAG-C
and its effect on oocyte maturation is due to the C-terminal FLAG-tag
(i.e., the C-terminal tag might have disturbed the disappearance of
P100-FLAG-C), we carried out a similar set of experiments with mRNA
encoding N-terminally FLAG-tagged P100 (N-FLAG-P100).We observed
no disappearance of N-FLAG-P100 during oocyte maturation (Fig. 5B)
and a similar retardation of the maturation kinetics with oocytes
expressing N-FLAG-P100 to that observed with P100-FLAG-C (Fig. 5A).
When oocytes were injected with one-tenth the amount of P100-
FLAG-CmRNA and treated with progesterone, a small amount of P100-
FLAG-C was expressed and both the endogenous P100 and the
expressed P100-FLAG-C disappeared, suggesting that both the endog-
enous and the exogenous P100 are subjected to degradation (Fig. 6A).
Furthermore, we examined the stability of P100-FLAG-C protein during
maturation by injecting a morpholino antisense oligonucleotide (MO)
(Fig. 6B). When an MO for P100 was injected into P100-FLAG-C-
expressing oocytes before the addition of progesterone, the amount of
P100-FLAG-C decreased almost as fast as the endogenous P100 during
oocyte maturation. This effect was speciﬁc for P100 MO because a
control MO did not affect the amount of P100-FLAG-C during
maturation. In addition, both control and P100 MO had no signiﬁcant
effect on the disappearance of the endogenous P100. These experiments
are consistent with the hypothesis that both the endogenous P100 and
the FLAG-tagged P100 proteins are rapidly degraded after the addition
of progesterone, but new FLAG-tagged P100 protein is continuously
synthesized from the injected mRNA whereas the translation of the
endogenous P100 mRNA would be somehow inhibited.
P100 overexpression inhibits the accumulation of c-Mos and cyclin B1
during oocyte maturation
Since we found that P100 overexpression represses mRNA transla-
tion and also affects the kinetics of oocyte maturation, we examined
whether the accumulation of proteins that are normally synthesized
during oocyte maturation would be repressed in P100-overexpressing
oocytes. To this end, oocytes were microinjected with the P100-FLAG-C
mRNA, treated with progesterone, and collected at 30-min intervals
(Figs. 7A and B). The oocyte lysates were analyzed by western blotting.
Whereas in control oocytes microinjected with water, c-Mos was well
detected 4.5 h after the addition of progesterone, it was detected only
7 h after progesterone addition in P100 overexpressing oocytes. The
accumulation of cyclin B1 was also occurred later in P100-over-
expressing oocytes (9.5 h) than in water-injected oocytes (7.5 h). The
activation of MAP kinase, revealed by phosphorylation of the enzyme,
was also slower in P100-overexpressing oocytes (7.5 h) than in water-
injected oocytes (5.5 h). To compare the levels of the accumulation of c-
Mos and cyclin B1 between P100-overexpressing and control oocytes,
the lysates of the same time points were analyzed in parallel (Fig. S3).
Both c-Mos and cyclin B1 accumulated less in P100-overexpressing
oocytes than in control oocytes, whichwas clearly evident in the lysates
at 10 and 12 h after progesterone addition. The amount of c-mos and
cyclin B1 mRNAs in matured oocytes overexpressing P100 was not
signiﬁcantly different from that in matured control oocytes, as assessed
by quantitative RT-PCR (Fig. S4), indicating that the P100
Fig. 4. Effect of P100 overexpression on protein synthesis in oocytes. (A) Analysis of protein synthesis in oocytes injected with P100-FLAG-CmRNA. Oocytes were incubated with [35S]
methionine and cysteine for 16 h and lysates of the oocytes were analyzed by SDS-PAGE. The radioactivity in the areas migrating faster than P100 (indicated by a bracket) was
quantiﬁed. (B–C) Tethering assay. Oocytes were injected with mRNA encoding MS2 or MS2-P100. Expression of MS2 and MS2-P100 protein was analyzed by incubating the oocytes
in [35S] methionine and cysteine for 19 h (B). (C) Seven hours after the ﬁrst injection, [32P]-labeled and capped ﬁreﬂy luciferase reporter mRNAs either containing (Luc-MS2) or not
containing (Luc-ΔMS2) MS2-binding sites were injected. After 17 h, oocytes were harvested and ﬁreﬂy luciferase activity was measured (left). Fireﬂy luciferase activity in oocytes is
shown relative to the case of Luc-ΔMS2-mRNA-injected oocytes expressing MS2 protein, which was set to 100%. The stability of [32P]-labeled luciferase mRNAs in oocytes expressing
MS2 and MS2-P100 was examined immediately after microinjection (0 h) and after 16 h of incubation (right). The relative count of [32P]-labeled mRNA normalized to the value at
0 h, which was 100%, is shown in boxes. Total RNA served as recovery and loading controls. (D) Oocytes were injected with mRNA encoding MS2 or MS2-P100. Seven hours after the
ﬁrst injection, capped CATmRNAwas injected and expression of CAT protein was analyzed by incubating the oocytes in [35S] methionine and cysteine. (E) Oocytes were injected with
or without (−) P100-FLAG-CmRNA. Seven hours after the ﬁrst injection, capped Rluc-β-globinmRNA was injected. After 17 h, oocytes were harvested and Renilla luciferase activity
was measured.
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immature and matured oocytes.
To investigatewhetherdownstreamevents of oocytematurationwere
also affected by the P100 overexpression, oocytes were collected at 1-
h intervals after GVBD (Fig. 7C). In uninjected oocytes, c-Mos was easily
detected at the time of GVBD and continued to accumulate during the
maturation process. Cyclin B1 was detectable in stage VI oocytes and
increased in its amount after GVBD. Cyclin B1 further accumulated at 2 to
3 h after GVBD, at which time control oocytes proceeded to meiosis II, asjudged from histone H1 kinase activity. In P100-overexpressing oocytes,
the protein levels of c-Mos and cyclin B1 at GVBDwere initially the same
as those in control oocytes. Although slightly less c-Mos accumulated in
P100-overexpressing oocytes than in control oocytes, the accumulation of
cyclin B1 at 2 to 3 h after GVBD was signiﬁcantly impaired in P100-
overexpressing oocytes. CPEB was degraded upon maturation, and the
amountof xRAP55Aremainedconstantasdescribedpreviously (Hakeand
Richter, 1994; Tanaka et al., 2006). There was no striking difference
between the amounts of these proteins in P100-overexpressing oocytes
Fig. 5. Inhibition of maturation in oocytes overexpressing P100-FLAG-C. (A) P100 overexpression during oocyte maturation. Stage VI oocytes were injected with 45 ng of P100-FLAG-
C mRNA (closed circles), 45 ng of N-FLAG-P100 mRNA (open squares), 45 ng of FLAG-xRAP55A mRNA (open triangles), or 4.5 ng of P100-FLAG-C mRNA (closed triangles), or not
injected (closed squares). They were incubated for 16–18 h, and then stimulated with progesterone (PG). Oocytes were scored as a fraction of time for GVBD. Two representative
experiments are shown. At least 45 oocytes were analyzed for each condition in experiment 1, and at least 71 oocytes were analyzed in experiment 2. Oocytes incubated in MBSH
without progesterone were not induced to mature at all (No PG, open circles). (B) Oocytes uninjected (lanes 1–3) or injected with 35 ng of N-FLAG-P100mRNA (lanes 4–6) or 35 ng
of P100-FLAG-CmRNA (lanes 7–9) were induced tomature with progesterone (lanes 2, 3, 5, 6, 8 and 9). Lysates from stage VI andmatured oocytes were analyzed by immunoblotting
with anti-P100 antibody. Positions of endogenous P100, N-FLAG-P100 and P100-FLAG-C are indicated.
280 Y. Nakamura et al. / Developmental Biology 344 (2010) 272–283and those inuninjected controls. These results suggest that P100 regulates
the translation of speciﬁc maternal mRNAs to cause oocytematuration to
progress.
Discussion
Wehave provided several lines of evidence that Xenopus P100 is an
RNA binding component of cytoplasmic storedmRNPs. First, P100was
identiﬁed in complexes associated with FRGY2 and xRAP55A, both of
which are components of stored mRNPs (Tanaka et al., 2006). Second,
upon the fractionation of oocyte lysates with a sucrose gradient, P100
distributed predominantly in ribosome-free mRNP fractions, which
indicates P100 is a component of stored and translationally repressed
maternal mRNPs. Third, P100 was covalently bound to adenylated
RNAs by UV-crosslinking. Finally, most of the known stored mRNP
components were coimmunoprecipitated with anti-P100 antibody
from stage I–III oocytes. Previously a protein of ∼100-kDa, called
mRNP6, was identiﬁed as a stored mRNP component in previtello-
genic oocytes, although its molecular identity was not determined
(Darnbrough and Ford, 1981; Murray et al., 1991). Our data suggest
that mRNP6 might correspond to P100. We previously showed that
the interaction of xRAP55A with FRGY2 is RNA-dependent in stage VI
oocytes, while xRAP55A associates with Xp54 in a partly RNA-
independent manner (Tanaka et al., 2006). The data presented in this
paper together with a recent study by Minshall et al. (2007)
demonstrate that the association of P100 with several proteins
including Xp54, xRAP55A, xRAP55B, 4E-T and CPEB but not with
FRGY2 is at least in part RNA-independent in small oocytes (Minshall
et al., 2007). Transcription is highly active in small oocytes and a large
pool of stored mRNPs is produced during this stage. Multiple
translational repressors might associate with each other and function
cooperatively to store newly synthesized mRNAs.
We found that P100 repressed translation of the reporter mRNA
that was microinjected into oocytes. Translational repression was
enhanced when P100 was tethered to the reporter mRNA. Thus ourresults with reporter mRNAs suggest that P100 functions as a
translational repressor. In contrast, we found that P100 overexpres-
sion did not signiﬁcantly affect global protein synthesis in oocytes,
monitored by [35S] methionine and cysteine incorporation. Over-
expression of Pat1p in yeast leads to a global repression of translation
and accumulation of mRNAs in P-bodies (Coller and Parker, 2005).
Efﬁcient translational repression and P-body assembly, which occur
during glucose deprivation, require Pat1p. It is possible that, because a
large proportion of maternal mRNAs are translationally repressed in
oocytes and those mRNAs are already associated with endogenous
P100, doubling the amount of P100 by injecting the P100mRNAwould
not have signiﬁcantly affected global protein synthesis in oocytes.
Alternatively, these differences between yeast Pat1p and Xenopus
P100 on translation could be attributed to the low homology between
them, one being a general repressor and the other not. There are two
Pat1p homologues in vertebrates (Fig. 1A).Whereas P100 is an oocyte-
speciﬁc protein, xPat1b started to accumulate in late oogenesis and
was expressed during early development (Fig. S2). There seems to be a
switchover from P100 to xPat1b during late oogenesis and oocyte
maturation. Future work is necessary to clarify whether P100 and
xPat1b,which are expressed differentially, are functionally equivalent.
Yeast Pat1p functions as a complex with Lsm1p-7p in activating
mRNA decapping (Bonnerot et al., 2000; Bouveret et al., 2000; Tharun
et al., 2000). Pat1p has ﬁve domains conserved among fungal species
and through distinct domains associates with RNA and Dcp1p, Lsm1p
and Edc3p, all of which are proteins involved in the decapping process
(Pilkington and Parker, 2008). We found that P100 interacts with
Lsm1 in Xenopus oocytes, thus presumably with the Lsm1–7 complex,
because Lsm1 is the only unique component of the cytoplasmic Lsm1–
7 complex. Although we do not know whether P100 promotes
decapping, it is reported that there is no detectable decapping activity
in Xenopus oocytes (Zhang et al., 1999). The absence of decapping
activity in oocytes could make it possible that P100-tethered mRNAs
are stored in a stable state and we could observe that P100 inhibits
translation of reporter mRNAs (see below). Recently in Caenorhabditis
Fig. 7. P100overexpressionaffects the accumulationof c-Mos andcyclinB1. (A–B)Oocytes
were injected either with 45 ng of P100-FLAG-C mRNA (closed circles) or water (open
squares), or not injected (closed squares). They were incubated for 12–14 h, and then
stimulatedwithprogesterone(PG). Oocyteswere scored as a fraction of time forGVBD(A).
Every 30 min after progesterone addition, oocytes injected with water or P100-FLAG-C
mRNAwere collected and analyzed by immunoblotting (B). The sample at 0.5 h of water-
injected oocytes is missing in immunoblots for c-Mos, cyclin B1 and RAP55A. (C) Stage VI
oocytes not expressing or expressing P100-FLAG-C were collected (lanes 1 and 6) or
induced to mature with progesterone. The appearance of white spots was examined at 1-
h intervals. At 8 h after the addition of progesterone, oocytes that underwent GVBD (0 h;
lanes 2 and 7)were collected and those further incubated for 1 h (lanes3 and8), 2 h (lanes
4 and 9) and 3 h (lanes 5 and 10) after GVBD were then collected. Oocyte lysates were
analyzed by immunoblotting or for histone H1 kinase activity.
Fig. 6. Stability of P100 during oocyte maturation. (A) Oocytes uninjected (lanes 1 and
2) or injected with 4.5 ng (lanes 3 and 4) or 45 ng (lanes 5 and 6) of P100-FLAG-CmRNA
were induced to mature with progesterone (lanes 2, 4 and 6). Lysates from stage VI and
matured oocytes were analyzed by immunoblotting with anti-P100 antibody. (B) Stage
VI oocytes were injected with 45 ng of P100-FLAG-C mRNA and incubated for 12 h.
Oocytes were then injected with 20 ng of control MO or P100 MO. After an additional
12 h incubation, oocytes were induced to mature with progesterone. Every 2 h after
progesterone addition, oocytes were harvested and analyzed for the endogenous P100
(top panels) or P100-FLAG-C (bottom panels).
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Pat1p. PATR-1 is expressed primarily in somatic tissues, where it is an
integral component of mRNP granules (Boag et al., 2008; Gallo et al.,
2008). A homozygous null mutant of PATR-1 produces offspring with
arrested development during the late embryonic or early larval stages.
Human Pat1b/PatL1 is localized to P-bodies in cultured cells and
required for P-body formation (Scheller et al., 2007). Thus, the
translational repression activity of Pat1p homologues appears to be
conserved in various organisms.
P100 predominantly distributed to ribosome-free mRNP fractions
when oocyte lysates were fractionated in a sucrose gradient. In this
regard, P100 is an mRNP component that mostly, if not exclusively,
associates with stored mRNAs. Given this, the ﬁnding that P100
disappears concomitant with GVBD raised the interesting possibility
that P100 is involved in the storage of a class of mRNAs that are
unmasked during oocyte maturation. Consistent with this, the
accumulation of c-Mos and cyclin B1 was impaired in maturing
oocytes that overexpressed P100. Further, we observed that P100-
overexpressing oocytes undergo GVBD very poorly. These observa-
tions therefore suggest that P100 should disappear during oocyte
maturation with normal kinetics and are consistent with the
hypothesis that P100 represses translation of speciﬁc mRNA(s) such
as c-mos and cyclin B1 required for oocyte maturation.
Although it is yet unclear how P100 represses translation, the RNA
binding afﬁnity of Pat1p and the interaction of P100with other proteins
may explain how P100 is recruited to stored mRNPs. In Xenopus
immature oocytes many mRNAs that will be unmasked during oocyte
maturation are stored having short poly(A) tails (Mendez and Richter,2001; Radford et al., 2008). The yeast Lsm1p–7p–Pat1p complex can
associate with the 3′ end of oligo(A)-tailed mRNAs in vivo and in vitro,
indicating that this complex has the intrinsic ability to distinguish
between oligoadenylated and polyadenylated mRNAs (Tharun and
Parker, 2001; Chowdhury et al., 2007). Thus, if one assumes that
Xenopus Lsm1–7–P100 complex has a similar RNA binding afﬁnity with
that of yeast Lsm1p–7p–Pat1p complex, mRNAs that are stored in
282 Y. Nakamura et al. / Developmental Biology 344 (2010) 272–283oocytes with short poly(A) tails could be good substrates for the Lsm1–
7–P100 complex. Further, many mRNAs that will be activated during
oocyte maturation carry CPEs in their 3′UTRs (Richter, 2007; Radford
et al., 2008). As P100 and CPEB interact with each other (at least in small
oocytes) (Minshall et al., 2007 and this study), P100 and possibly Lsm1–
7 complex could be recruited to CPE-carryingmRNAs preferentially. The
timing of translational activation differs among CPE-carryingmRNAs: c-
mos is translated earlier during oocytematuration, prior toGVBD (‘early
class mRNA’), whereas cyclin B1 is activated later, coincident with or
after GVBD (‘late classmRNA’). The timing depends on the combination
and contexts of the CPEs and other cis-elements in 3′UTRs (Charles-
worth et al., 2000, 2006; Nakahata et al., 2003;Wang et al., 2008; Pique
et al., 2008; Belloc and Mendez, 2008). The disappearance of P100 may
be required for the correct temporal translational activation of the late
class mRNAs. One key future issue is to determine whether P100
represses cytoplasmic polyadenylation during oocyte maturation.
Further functional analysis of protein complexes containing multiple
mRNP components will shed light on these issues.
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